These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14994533)

  • 1. Prospects of thermography in modern medicine: a study of spatial changes in human skin temperature induced by administration of Perftoran.
    Ivanitsky GR; Deev AA; Maevsky EI; Khizhnyak EP; Khizhnyak LN
    Dokl Biol Sci; 2003; 393():496-500. PubMed ID: 14994533
    [No Abstract]   [Full Text] [Related]  

  • 2. THERMOGRAPHY IN THE MANAGEMENT OF VARICOSE VEINS AND VENOUS INSUFFICIENCY.
    ROSENBERG N; STEFANIDES A
    Ann N Y Acad Sci; 1964 Oct; 121():113-7. PubMed ID: 14237505
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of perftoran on pharmacokinetics of hydrophilic drugs].
    Pshenkina NN
    Eksp Klin Farmakol; 2011; 74(12):23-6. PubMed ID: 22379878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Brain electric activity of animals exposed to perfluorocarbon emulsions].
    Vorob'ev VV; Iarkov AV; Kukukshkin NI; Sologub GR; Gal'chenko AA
    Patol Fiziol Eksp Ter; 1991; (2):19-23. PubMed ID: 1881700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of perftoran on macroglobulin content in the plasma and peritoneal exudate of rats with acute exudative inflammation (peritonitis).
    Lykova OF; Romanova TV; Moiseeva LM; Konysheva TV; Grigor'ev EV; Zorin NA
    Bull Exp Biol Med; 2004 Oct; 138(4):351-3. PubMed ID: 15665942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perftoran as a means modulating the functional activity of liver macrophages.
    Kovelenov AY; Mikhal'tsov AN; Malkov AN
    Bull Exp Biol Med; 2002 Dec; 134(6):551-3. PubMed ID: 12660835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of perftoran for the lengthening of the period of tolerance to the experimental acute lethal hypoxia (the apnea model)].
    Skorik VI; Shilov VV; Sudus AV; Zuev VV
    Biull Eksp Biol Med; 1997 Oct; 124(10):477-80. PubMed ID: 9410188
    [No Abstract]   [Full Text] [Related]  

  • 8. [Perftoran--blood substitute with oxygen transport function].
    Golubev AM
    Biull Eksp Biol Med; 1998 May; 125(5):484-92. PubMed ID: 9644539
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural and functional characteristics of erythrocyte membranes and their correction with perftoran.
    Karmen NB; Milyutina NP; Orlov AA
    Bull Exp Biol Med; 2005 May; 139(5):562-4. PubMed ID: 16224549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infrared thermography for the demonstration of a heparinoid-effect on the human skin].
    Böttger EM; Heindl I; Müller E; Tronnier H
    Z Hautkr; 1977 Jul; 52(14):743-8. PubMed ID: 70890
    [No Abstract]   [Full Text] [Related]  

  • 11. [The immunological effects of perftoran].
    Pluzhnikov NN; Lobzin IuV; Kovelenov AIu; Zhelezkova EV; Gusev DA
    Eksp Klin Farmakol; 1998; 61(5):34-6. PubMed ID: 9854631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of protective effect of perftoran on a skin flaps].
    Zhitkov MIu; Orlov AA; Grigor'ian AS; Ippolitov VP; Chupakhin PV
    Stomatologiia (Mosk); 2002; 81(5):11-4. PubMed ID: 12532880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of perftoran on the morphofunctional status of the digestive system organs in experimental duodenal ulcer].
    Karimov KhIa; Daminov ShN; Khoroshaev VA
    Eksp Klin Farmakol; 1999; 62(4):33-6. PubMed ID: 10513333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The use of perftoran in patients with burn shock].
    Kligunenko EN; Slinchenkov VV; Leshchev DP
    Klin Khir; 2000; (4):41-3. PubMed ID: 10857343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SKIN TEMPERATURE OF NORMAL AND VARICOSE LEGS AND SOME REFLECTIONS ON THE ETIOLOGY OF VARICOSE VEINS.
    HAEGER KH; BERGMAN L
    Angiology; 1963 Sep; 14():473-9. PubMed ID: 14057649
    [No Abstract]   [Full Text] [Related]  

  • 16. [Feasibility study of perftoran for protection of the brain from ischaemia in operations on extracranial arteries].
    Putintsev AM; Sergeev VN; Filip'ev DE; Sin'kov MA; Ignat'eva TF; Mal'chenko AL
    Angiol Sosud Khir; 2008; 14(1):31-6. PubMed ID: 19156027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Blood substitutes].
    Tomoda H
    Nihon Rinsho; 1983 Dec; 41(12):2803-9. PubMed ID: 6371303
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoprotective effect of perftoran.
    Mukhutdinova FI; Khafiz'janova RKh; Triandafilov KA; Mukhutdinov DA
    Bull Exp Biol Med; 2010 Nov; 149(6):724-6. PubMed ID: 21165430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PFC as blood substitutes--an overview.
    Geyer RP
    Prog Clin Biol Res; 1983; 122():157-68. PubMed ID: 6878357
    [No Abstract]   [Full Text] [Related]  

  • 20. Thermologic methods in clinical pharmacology-skin temperature measurement in drug trials.
    Ring EF; Engel JM; Page-Thomas DP
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):20-4. PubMed ID: 6698656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.